In line with these functional data, our findings revealed a significant link between reduced occludin expression and unfavorable histopathological and clinical tumor parameters in several different cancer entities including colorectal and pancreatic adenocarcinoma, serous high-grade ovarian cancer, as well as clear cell and papillary renal cell carcinoma (RCC). The gene discussed is OCLN; the disease is renal cell adenocarcinoma.